Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-001483 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
91,690
Total Value
$609,145.60
P&L
+inf% (+$5,501,780.60)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 2, 2026 | Sale | 1,920 | $74.13 | $142,329.60 | 191,451 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 2, 2026 | Sale | 4,080 | $75.20 | $306,816.00 | 187,371 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 6, 2026 | Sale | 2,000 | $80.00 | $160,000.00 | 185,371 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 83,690 | $0.00 | $0.00 | 83,690 | Direct | โ | View Details |